A Glycosylated Cationic Block Poly(β-peptide) Reverses Intrinsic Antibiotic Resistance in All ESKAPE Gram-Negative Bacteria

Angew Chem Int Ed Engl. 2020 Apr 20;59(17):6819-6826. doi: 10.1002/anie.201914304. Epub 2020 Feb 19.

Abstract

Carbapenem-resistant Gram-negative bacteria (GNB) are heading the list of pathogens for which antibiotics are the most critically needed. Many antibiotics are either unable to penetrate the outer-membrane or are excluded by efflux mechanisms. Here, we report a cationic block β-peptide (PAS8-b-PDM12) that reverses intrinsic antibiotic resistance in GNB by two distinct mechanisms of action. PAS8-b-PDM12 does not only compromise the integrity of the bacterial outer-membrane, it also deactivates efflux pump systems by dissipating the transmembrane electrochemical potential. As a result, PAS8-b-PDM12 sensitizes carbapenem- and colistin-resistant GNB to multiple antibiotics in vitro and in vivo. The β-peptide allows the perfect alternation of cationic versus hydrophobic side chains, representing a significant improvement over previous antimicrobial α-peptides sensitizing agents. Together, our results indicate that it is technically possible for a single adjuvant to reverse innate antibiotic resistance in all pathogenic GNB of the ESKAPE group, including those resistant to last resort antibiotics.

Keywords: antimicrobial resistance; carbapenems; efflux pumps; medicinal chemistry; β-peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Glycosylation
  • Gram-Negative Bacteria / drug effects*
  • Microbial Sensitivity Tests
  • Peptides / chemistry*
  • Peptides / pharmacology*
  • Protein Conformation, beta-Strand

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Peptides